Reuters - Health Report

Click to View in Browser

Friday, September 15, 2017

GSK's three-in-one inhaler gets positive opinion from EU agency

(Reuters) - GlaxoSmithKline said on Friday that a European Medicines Agency (EMA) panel has recommended the company's three-in-one inhaled lung drug.

Pfizer, Astellas prostate cancer drug promising in late-stage trial

(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.

ACA Medicaid expansion tied to earlier cancer care for the poor

(Reuters Health) - After the Affordable Care Act (ACA) helped reduce the number of uninsured Americans, more low-income adults got cancer diagnosed when it was less advanced and potentially easier to treat, a recent study suggests.

Santhera shares plummet after negative CHMP opinion

ZURICH (Reuters) - Swiss drugmaker Santhera's shares plunged nearly 60 percent in early trading on Friday, after a European panel recommended against approving one of its drugs to be used in patients with Duchenne muscular dystrophy (DMD).

Obamacare enrollment to fall in 2018 and beyond after cuts: CBO

NEW YORK (Reuters) - Enrollment on the Obamacare health insurance exchanges in 2018 and later years is expected to be less than previously forecast, dampened by the Trump administration's decision to pull back enrollment efforts, the U.S. Congressional Budget Office said on Thursday.

Mental disorders, poor diets and tobacco make the world sick

LONDON, Sept 15 (Reuters) - Heart disease and tobacco ranked with conflict and violence among the world's biggest killers in 2016, while poor diets and mental disorders caused people the greatest ill health, a large international study has found.

Halozyme to license drug delivery tech to Roche, Bristol-Myers

(Reuters) - U.S. drugmaker Halozyme Therapeutics Inc said on Thursday it would license its drug delivery technology to Bristol-Myers Squibb Co and Swiss drugmaker Roche in separate collaborations.

Challenge of Allergan tribal patent deal in uncharted legal territory

(Reuters) - As generic drug manufacturers are gearing up to argue that a deal Allergan Plc made with a Native American tribe to shield patents from administrative review is a sham, some experts say the generic companies are in uncharted legal territory.

Outbreak of disease carried by mosquitoes halts blood donation in Rome

ROME (Reuters) - Italian health officials have banned residents across half of Rome from donating blood because of an outbreak of the painful, mosquito-borne illness Chikungunya.

Exclusive: Prosecutors identify Insys founder as unindicted co-conspirator in opioid case

BOSTON (Reuters) - U.S. prosecutors have identified Insys Therapeutics Inc's billionaire founder as an unindicted co-conspirator in a case accusing six former executives and managers of participating in a scheme that involved bribing doctors to prescribe a fentanyl-based drug, according to a court document.